Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy [Phase 3]
A Phase 3 trial studied the combination of aleglitazar with metformin in adults with Type 2 diabetes inadequately controlled on sulfonylurea…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes. [Phase 2]
A Phase 2 dose-titration study of GK Activator (2) in patients with type 2 diabetes has completed, sponsored by Hoffmann-La Roche.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy [Phase 3]
A Phase 3 trial evaluating the addition of aleglitazar to metformin in adults with type 2 diabetes inadequately controlled on metformin mono…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment [Phase 1]
Phase 1 study evaluating RO4998452 in adults with type 2 diabetes mellitus and varying degrees of renal impairment; the trial status is comp…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes. [Phase 2]
A Phase 2 long-term safety and tolerability study of GK Activator (2) in adults with Type 2 diabetes has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO6807952 in Patients With Diabetes Mellitus Type 2 [Phase 1]
A Phase 1 study of RO6807952 in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease [Phase 2]
Phase 2 trial evaluating the effect of Aleglitazar on cardiac energetics and function in adults with Type 2 diabetes mellitus and no history…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Study of RO6807952 in Patients With Diabetes Mellitus Type 2 [Phase 2]
Phase 2 study of RO6807952 in Type 2 diabetes mellitus was terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy [Phase 3]
A Phase 3 trial comparing taspoglutide to insulin glargine in insulin-naïve Type 2 diabetes patients inadequately controlled on metformin an…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes. [Phase 1]
A completed Phase 1 study evaluating the drug-drug interaction between GK Activator (2) and simvastatin in adults with Type 2 diabetes melli…
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin [Phase 2]
A Phase 2 trial of RO6811135 in patients with Type 2 diabetes mellitus inadequately controlled with metformin has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment [Phase 2]
Clinical trial update on Aleglitazar in patients with type 2 diabetes and moderate renal impairment. The Phase 2 study has completed.
-
CLINICAL_TRIALS other · 2016-11-02Clinical Trial Update: A Study of Taspoglutide in Type 2 Diabetic Patients [Phase 1]
A Phase 1 study of Taspoglutide in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Connecting Smartphones With Electronic Health Record to Facilitate Behavioral Goal Monitoring in Diabetes Care [EARLY_Phase 1]
An early-phase 1 study tested linking smartphone data with electronic health records to monitor behavioral goals in diabetes care. The trial…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Role of Interleukin-6 in Exercise [NA]
A completed clinical trial update from the University of Zurich investigating the role of interleukin-6 in exercise for individuals with Typ…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus [NA]
This clinical trial update summarizes a completed Vanderbilt University study on the role of the duodenum in the pathogenesis of insulin res…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: The Diabetes Medication Adherence Promotion Intervention Trial [NA]
This document reports the completion of a clinical trial evaluating a diabetes medication adherence promotion intervention in adults with Ty…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes [Phase 3]
Phase 3 trial assessing the efficacy and safety of evogliptin added to metformin in patients with type 2 diabetes; the study status is compl…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes
A completed clinical trial assessing the safety of initiating Biphasic Insulin Aspart 30 in hospitalized patients with Type 2 diabetes melli…
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
An observational study sponsored by Novo Nordisk evaluates blood glucose control in people with diabetes using modern insulin; the study has…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Randomized Trial of Diabetes Prevention Through Lifestyle Change in India [NA]
This completed randomized trial in India evaluated whether a structured lifestyle change program could prevent type 2 diabetes in high-risk …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes [Phase 4]
This Phase 4 clinical trial compares biphasic insulin alone to biphasic insulin combined with insulin aspart, with or without metformin, in …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes
This completed observational study assessed the efficacy and safety of NovoMix 30 in diabetes patients, including type 1 and type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients
An observational study assessing the safety and efficacy of biphasic insulin aspart in adults with type 2 diabetes.
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes
Completed observational study evaluating quality of life and clinical outcomes in people with diabetes treated with NovoMix 30.